Phase I and pharmacokinetic study of CT-322 (BMS-844203), a targeted Adnectin inhibitor of VEGFR-2 based on a domain of human fibronectin (Q34158482)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Phase I and pharmacokinetic study of CT-322 (BMS-844203), a targeted Adnectin inhibitor of VEGFR-2 based on a domain of human fibronectin |
scientific article |
Statements
1 reference
Phase I and pharmacokinetic study of CT-322 (BMS-844203), a targeted Adnectin inhibitor of VEGFR-2 based on a domain of human fibronectin (English)
1 reference
Anthony W Tolcher
1 reference
Christopher J Sweeney
1 reference
Kyri Papadopoulos
1 reference
Amita Patnaik
1 reference
Elena G Chiorean
1 reference
Alain C Mita
1 reference
Kamalesh Sankhala
1 reference
Eric Furfine
1 reference
Jochem Gokemeijer
1 reference
Lisa Iacono
1 reference
Cheryl Eaton
1 reference
Bruce A Silver
1 reference
Monica Mita
1 reference
11 January 2011
1 reference
1 reference
17
1 reference
363-371
1 reference
Identifiers
1 reference
1 reference